Amphastar Pharmaceuticals

AMPH · NASDAQ

$25.94−$0.20 (−0.77%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $26.14

Latest news

Press releaseSep 1, 6:00 AM ETPRNewswire
Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference
NewsAug 24, 5:06 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsAug 6, 4:10 PM ET
Amphastar Pharma Q2 Adj. EPS $0.91 Beats $0.62 Estimate, Sales $183.903M Beat $182.055M Estimate
Press releaseAug 6, 4:05 PM ETPRNewswire
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026
Press releaseJul 29, 6:00 AM ETPRNewswire
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026
NewsJul 24, 6:25 AM ETStjepan Kalinic
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
NewsJul 8, 6:16 AM ET
Amphastar Pharmaceuticals Unit International Medication Systems Receives FDA Warning Letter Regarding Violations Of Current Good Manufacturing Practice At IMS's Drug Manufacturing Facility In California
NewsJun 29, 12:30 PM ETAvi Kapoor
Crude Oil Gains 2%; Comcast Shares Spike Higher
NewsMay 8, 1:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsMay 8, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsMay 7, 4:24 PM ET
Amphastar Pharma Q1 Adj. EPS $0.42 Misses $0.70 Estimate, Sales $171.171M Miss $173.392M Estimate
Press releaseMay 7, 4:05 PM ETACCESS Newswire
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026
Press releaseMay 6, 6:00 AM ETACCESS Newswire
Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference
Press releaseApr 30, 6:00 AM ETACCESS Newswire
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026
Press releaseApr 6, 6:00 AM ETACCESS Newswire
Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference
NewsFeb 27, 7:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
Press releaseNov 24, 6:00 AM ETACCESS Newswire
Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference
NewsNov 7, 6:44 AM ET
The Analyst Verdict: Amphastar Pharma In The Eyes Of 4 Experts
NewsNov 6, 6:12 AM ET
Earnings Scheduled For November 6, 2025
NewsOct 24, 4:28 PM ET
Amphastar Pharmaceuticals Appoints Chengong As Exclusive Distributor For BAQSIMI In Greater China Under 10-Year Agreement
NewsOct 22, 8:01 AM ET
Demystifying Amphastar Pharma: Insights From 4 Analyst Reviews
NewsOct 9, 9:31 AM ETVandana Singh
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs
NewsAug 12, 1:38 PM ETVandana Singh
Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum
Press releaseAug 11, 6:00 AM ETACCESS Newswire
Amphastar Announces FDA Approval for Iron Sucrose Injection, USP
Press releaseAug 7, 4:05 PM ETACCESS Newswire
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025
NewsMay 6, 11:04 AM ET
Earnings Outlook For Amphastar Pharma
Press releaseMar 5, 6:00 AM ETACCESS Newswire
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
NewsFeb 21, 2:17 PM ETAvi Kapoor
Top 2 Health Care Stocks That May Rocket Higher This Month

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference

12 Health Care Stocks Moving In Monday's After-Market Session

Amphastar Pharma Q2 Adj. EPS $0.91 Beats $0.62 Estimate, Sales $183.903M Beat $182.055M Estimate

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026

Two Years to Build or Pay 200% — Which US Pharma Stocks Win?

Amphastar Pharmaceuticals Unit International Medication Systems Receives FDA Warning Letter Regarding Violations Of Current Good Manufacturing Practice At IMS's Drug Manufacturing Facility In California

Crude Oil Gains 2%; Comcast Shares Spike Higher

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Amphastar Pharma Q1 Adj. EPS $0.42 Misses $0.70 Estimate, Sales $171.171M Miss $173.392M Estimate

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026

Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026

Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference

12 Health Care Stocks Moving In Friday's Pre-Market Session

Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference

The Analyst Verdict: Amphastar Pharma In The Eyes Of 4 Experts

Earnings Scheduled For November 6, 2025

Amphastar Pharmaceuticals Appoints Chengong As Exclusive Distributor For BAQSIMI In Greater China Under 10-Year Agreement

Demystifying Amphastar Pharma: Insights From 4 Analyst Reviews

Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum

Amphastar Announces FDA Approval for Iron Sucrose Injection, USP

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025

Earnings Outlook For Amphastar Pharma

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

Top 2 Health Care Stocks That May Rocket Higher This Month